Skip to main content

Every American who has ever needed surgery, a scan, or a specialist referral knows the particular dread of those three words: “prior authorization required.” It means your doctor has already decided what you need. But before anything can happen, someone at your insurance company has to agree. That process can take hours, days, or weeks. It can end in an approval – or a denial letter that leaves patients scrambling, delaying care they were counting on.

For years, physicians have described the prior authorization system as one of the most damaging forces in American medicine. Not because it was designed to fail patients, but because in practice, it too often does. Now, a significant policy shift from the country’s largest health insurer is drawing attention – and raising real questions about whether this time, genuine reform is actually arriving.

The announcement is specific, it comes with timelines, and it sits within a broader wave of regulatory pressure that is reshaping how insurers handle prior authorization across the industry. Here is what is happening, why it matters, and what it means for patients and providers.

What UnitedHealthcare Actually Announced

UnitedHealthcare is eliminating authorization requirements for 30% of healthcare services that previously required insurer approval. The announcement, made on May 5, 2026, came directly from UnitedHealthGroup’s official newsroom.

By the end of 2026, UnitedHealthcare will eliminate an additional 30% of remaining prior authorizations, including select outpatient surgeries, some diagnostic tests like echocardiograms, and certain outpatient therapies and chiropractic care. A full list of affected services will be published on UHCProvider.com before the changes take effect.

To understand the significance of that number, you need some context about where things stand right now. Prior authorization is currently required for only 2% of UnitedHealthcare medical services. Of the authorizations that are submitted, around 92% are approved in less than 24 hours, on average. That paints a picture that is more favorable than critics suggest – but the number that matters most to physicians is not the approval rate. It’s the time and resources consumed getting there.

Within Medicare Advantage, UnitedHealthcare claims it has fewer prior authorization requirements than any other insurer. The company frames Tuesday’s move as an extension of a broader, ongoing effort to simplify care delivery and reduce administrative drag on providers.

CEO Tim Noel put it plainly. “Prior authorization is an essential safeguard but should only be used when it truly protects patients and improves care,” said Noel. “Eliminating these requirements is one more way we are working to make it easier for patients to get the care they need when they need it and ensure doctors can spend more time with their patients. We are committed to further improving and refining our processes to make reviews quicker, simpler and more efficient.”

The Scale of the Administrative Burden

To appreciate what this policy shift could mean in practical terms, it helps to understand the scale of what prior authorization demands from the medical system right now.

According to the American Medical Association’s 2024 Prior Authorization Physician Survey, physicians complete an average of 39 prior authorization requests per week, spending approximately 13 hours on the process. As a result, 89% report that prior authorization somewhat or significantly contributes to burnout.

To put that in practical terms: a physician working a standard 50-hour clinical week is losing 26% of available work time to prior authorization. That is time that could be spent seeing patients, reviewing test results, or following up on ongoing cases.

The patient consequences are just as alarming. Of the surveyed physicians, 93% reported that prior authorization causes patient care delays, with 82% stating it can sometimes lead to treatment abandonment. Additionally, 94% said that prior authorization has a somewhat or significantly negative impact on patient clinical outcomes, with more than 1 in 4 reporting that it caused a serious adverse event for a patient in their care.

Nearly one in four physicians (24%) reported in the AMA survey that prior authorization has led to a serious adverse event for a patient in their care, including hospitalization, permanent impairment, or death. These are not hypothetical harms. They are documented outcomes from a system that insurers, physicians, and federal regulators have been arguing over for years.

Prior authorization also significantly increases costs to the health care system, as 88% of physicians reported higher overall resource utilization. Because of prior authorization requirements and delays, patients often endure ineffective initial treatments, require additional office visits, seek immediate or emergency care, or face hospitalization. In other words, the tool intended to reduce unnecessary spending may be generating more of it.

One more data point is worth knowing: just one in 10 prior authorization requests that were denied in 2022 were appealed, according to a KFF analysis of Medicare Advantage data. That is particularly stark when one considers that the overwhelming majority of those appeals – 83.2% – resulted in the insurance company either partially or fully overturning the initial denial. Patients are not appealing denials they would almost certainly win. The process is too burdensome, too confusing, and too slow.

The Gold Card Program and Electronic Standardization

The 30% reduction announcement does not stand alone. It is part of a broader package of policy changes UnitedHealthcare has been rolling out across 2026.

The initiative also builds on an ongoing effort that includes expanding the first-of-its-kind national Gold Card program, which recognizes provider groups who consistently adhere to evidence-based care guidelines. The Gold Card program is significant because it targets the right problem: it removes prior authorization requirements for physicians who have already demonstrated they prescribe and order appropriately. The program would exempt physicians from prior authorization requirements if 90% of their requests had been approved in the preceding 12 months – and the cards would apply to items and services for at least one year.

On the technology side, UnitedHealthcare is also pushing for system-wide standardization of electronic submissions. On April 24, 2026, UnitedHealthcare championed an industry effort to standardize electronic prior authorization submission requirements, laying the groundwork for greater automation and interoperability. More than 70% of UnitedHealthcare’s prior authorizations will be part of the new standardized submission process by year-end.

This matters because fragmentation has been one of the core structural problems. Every insurer has had different submission formats, different portals, different documentation requirements. Each prior authorization request currently involves determining whether the service requires authorization, identifying the correct payer requirements, assembling the clinical documentation, submitting the request through the payer’s preferred channel – whether fax, phone, or portal – and following up on pending requests. Standardizing that process across insurers would cut a meaningful portion of that time, even before a single authorization is eliminated.

For comparison, Aetna, a CVS Health business, says it has already standardized 88% of its prior authorization volume, exceeding industry commitments.

Rural Healthcare: A Separate and Targeted Initiative

Separate from the 30% reduction announcement, UnitedHealthcare has been quietly rolling out a targeted policy for rural providers – a population that bears a disproportionate share of the prior authorization burden.

On April 20, 2026, UnitedHealthcare announced it is expanding support for rural healthcare communities by accelerating payments to more select hospitals nationwide and exempting many rural care providers from prior authorization requirements. These actions are designed to improve financial stability for rural hospitals, ease strain on care teams, and help ensure patients in rural communities can access high-quality care when and where they need it.

By the end of 2026, this program will cover approximately 1,500 rural hospitals, including all Critical Access Hospitals. This move is designed to improve the financial stability of rural institutions, which often operate on thin margins and with smaller administrative teams.

That model is currently being tried in nine states, with more to follow. The goal is to make this a nationwide policy by the end of 2026, meaning roughly 1,500 rural hospitals would benefit from the shift away from pre-approval for patient care delivery.

For rural patients – who may already travel significant distances to reach care – prior authorization delays carry an outsized cost. A denial or a multi-day wait for approval can mean a patient misses a narrow treatment window, or simply doesn’t return.

The Industry-Wide Pledge: Context and Credibility Questions

UnitedHealthcare’s announcement does not exist in a vacuum. It follows a broader industry-wide commitment to reform that was brokered in mid-2025 with direct involvement from the Trump administration.

In June 2025, over 60 major health insurers – including UnitedHealthcare, Aetna, Cigna, Humana, Elevance Health, and the Blue Cross Blue Shield Association plans – pledged to streamline the prior authorization process. HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz met with industry leaders to discuss their pledge to streamline and improve prior authorization processes for Medicare Advantage, Medicaid Managed Care, Health Insurance Marketplace, and commercial plans covering nearly eight out of 10 Americans. In a roundtable discussion hosted by HHS, health insurers pledged six key reforms aimed at cutting red tape, accelerating care decisions, and enhancing transparency for patients and providers.

Those pledges included reducing the number of services requiring preapproval, honoring prior authorizations during plan transitions, improving communication of denials and appeal options, and, by 2027, implementing a standardized electronic prior authorization process. The changes, applying across all forms of insurance over the next two years, could benefit more than 250 million Americans given the reach of the insurers involved.

However, provider groups were not uniformly convinced. “The pledge is not a mandate,” Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, acknowledged during a news conference. Multiple provider associations and patient advocacy groups said that little had changed over the prior year. “From where we sit, we’ve seen no change in the burdens both providers and beneficiaries must go through to get medically necessary care,” said David Lipschutz, co-director of the Center for Medicare Advocacy.

The AMA has also been cautious about industry pledges. In 2023, UnitedHealthcare and Cigna announced reductions in the number of services that require prior authorization. However, only 16% of physicians who work with UnitedHealthcare and 16% who work with Cigna reported that those changes actually reduced the number of prior authorizations they completed. Announced reforms and felt reforms are two different things for physicians on the ground.

Read More: How UnitedHealthcare Came to Represent Everything Wrong With U.S. Health Insurance

The Federal Regulatory Framework Tightening Around Insurers

The voluntary commitments are happening alongside binding federal regulations that are changing the operational baseline for all major insurers.

Under the 2024 CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), the Centers for Medicare and Medicaid Services is requiring impacted payers to send prior authorization decisions within 72 hours for expedited requests and seven calendar days for standard, non-urgent requests. These operational provisions carry a compliance date starting January 1, 2026, and the initial set of metrics must be reported by March 31, 2026.

That federal reporting requirement is already producing results. On March 31, 2026, UnitedHealthcare publicly reported prior authorization metrics and maintains that data on its website, along with additional context to help care providers, members, and the public better understand how prior authorization is used.

CMS is now extending that framework further. The 2026 CMS proposed rule on interoperability standards and prior authorization for drugs, released in April 2026, expands prior authorization reform beyond non-drug items and services directly into drugs covered under both medical and pharmacy benefits. It introduces requirements for electronic prior authorization, shorter decision timelines, more specific denial explanations, and standardized data exchange. The proposed rule is open for public comment until June 15, 2026.

The parallel push from regulators gives voluntary insurer pledges more weight than past commitments carried. Insurers that don’t move proactively face the prospect of more prescriptive rules. CMS Administrator Dr. Oz stated that the government will be tracking compliance closely and will consider regulation if insurers fail to meet the new standards.

Prior Authorization Transparency: A New Public Accountability Layer

One of the less-discussed but consequential pieces of the 2026 reforms is the new transparency requirement. Under the 2024 CMS Interoperability and Prior Authorization Final Rule, beginning in 2026, and annually thereafter, impacted payers must post certain aggregated prior authorization metrics from the previous year on their public-facing website.

That means, for the first time, patients and providers will have access to publicly reported data on how often insurers deny authorizations, how quickly they respond, and how many denials are reversed on appeal. This kind of structured accountability is new. Prior authorization has historically operated in a black box – with no consistent, standardized view of how individual insurers were performing.

A recent initiative led by the Blue Cross Blue Shield Association and AHIP found that participating plans reduced prior authorization requirements by about 11% overall, with reductions of more than 15% in Medicare Advantage. Those numbers will now be verifiable and comparable across insurers.

KFF reported that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, denying 4.1 million – about 7.7% of requests. Just 11.5% of denied requests were appealed, though 80.7% of those appeals overturned the initial denial. Those figures illustrate both the scale of the system and the extraordinary gap between how often denials hold up to scrutiny and how often patients bother to challenge them.

What to Do Now

For patients who regularly interact with the prior authorization system, this reform wave has practical implications – but it also has limits that are important to understand.

The most immediate change is in the category of care being affected. By the end of 2026, UnitedHealthcare will remove prior authorization requirements for certain outpatient surgeries, diagnostic tests such as echocardiograms, and some outpatient therapies and chiropractic care. If you or someone in your family relies on any of those services, it is worth checking with your provider and UnitedHealthcare directly to confirm whether a specific procedure will no longer require preapproval when the changes take effect.

The Gold Card program offers a practical shortcut for physicians. Providers with consistent, high-approval track records can apply to be recognized under the program, effectively removing themselves from routine authorization review for covered services. Patients whose doctors are enrolled in that program may experience faster access to care even before the broader reforms take hold.

The transparency piece matters in a way that most patients overlook. Because insurers are now required to publish denial rates, decision timelines, and appeal outcomes publicly, you have the right to look up how your insurer performs and to factor that into healthcare decisions. And if you receive a denial, the odds favor appealing it: as the data consistently shows, the majority of prior authorization denials that are appealed are overturned.

What remains uncertain is whether the broader voluntary pledge from the industry will be followed through with the consistency that patients and providers need. Past commitments have not always translated into changes that physicians feel on the ground. The federal regulatory framework now offers more structural accountability than previous reform cycles did – but enforcement, transparency, and political will still matter enormously.

The direction of change is clear. Whether the pace and depth of that change will match the scale of the problem is still being tested – and the people best positioned to hold insurers accountable are the patients and providers who document their experiences, exercise their right to appeal, and pay close attention to the new public metrics that insurers are now required to disclose. Numbers that were once hidden in a black box are now becoming part of the public record. That shift, quiet as it may seem, is not a small thing.

AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.

Read More: Blue Cross Blue Shield to Start Paying Out $2B in Settlements: How to Claim Yours